A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia

Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):294-5. doi: 10.1002/ajmg.b.30300.

Abstract

Exposure to atypical antipsychotic drugs such as valproate increases the expression of chaperones that assist in the folding of proteins in the endoplasmic reticulum (ER) including calreticulin, GRP78/BiP, GRP94, and PD1. This neuroprotective role may be involved in the pathophysiology of neuropsychiatric disorders such as schizophrenia and bipolar disorder. The 5'-flanking region of the human calreticulin gene was screened in 100 cases of schizophrenia by PCR/SSCA between -485 and +1 basepair (bp) relative to the transcription start site. A G > C point mutation was detected at -48 in a case of paranoid schizophrenia, which was not detected in 280 unrelated control subjects (560 chromosomes). This is the first report of mutation in relation with the calreticulin gene. The -48G > C mutation creates a CpG site at the core promoter region of the gene. The role of this mutation remains to be clarified in the pathophysiology of the disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Base Sequence
  • Calreticulin / genetics*
  • Conserved Sequence / genetics
  • DNA Mutational Analysis
  • Endoplasmic Reticulum Chaperone BiP
  • Germ-Line Mutation
  • Heterozygote
  • Humans
  • Male
  • Point Mutation*
  • Polymorphism, Single-Stranded Conformational
  • Promoter Regions, Genetic / genetics*
  • Schizophrenia / genetics*

Substances

  • Calreticulin
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human